Physician profile
Jennifer E Mullins
NPI 1912975707
$1,457.30
in general payments reported to CMS, 2019-2025
24 companies · $615 in 2025
The $615 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $44.13 · 2021: $44.03 · 2022: $171 · 2023: $233 · 2024: $239 · 2025: $615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $898 · Travel and Lodging: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $898.25 |
| Travel and Lodging | $189.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $283.32 | 2025 | |
| Sage Therapeutics, LLC | $161.35 | 2024-2025 | Zurzuvae |
| Daiichi Sankyo INC. | $134.03 | 2019-2024 | Injectafer |
| Pfizer INC. | $118.94 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $118.74 | 2019-2025 | |
| Exeltis, USA INC. | $105.09 | 2022-2025 | Slynd |
| Sumitomo Pharma America, INC. | $73.24 | 2023-2025 | Myfembree, Gemtesa |
| Abbvie INC. | $69.19 | 2022-2025 | |
| Astellas Pharma US INC | $64.53 | 2023-2024 | Veozah, Myrbetriq |
| Shield Therapeutics INC | $55.52 | 2025 | |
| Lundbeck LLC | $50.34 | 2023 | Abilify Maintena |
| Nestle Healthcare Nutrition INC. | $27.00 | 2022-2023 | |
| Roche Diagnostics Corporation | $24.94 | 2019 | |
| Axonics, INC. | $19.25 | 2024 | Axonics |
| Pacira Pharmaceuticals Incorporated | $19.20 | 2025 | Exparel |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $16.57 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.02 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.42 | 2023 | Gattex |
| Novo Nordisk INC | $14.87 | 2025 | Wegovy |
| Minerva Surgical, INC | $14.66 | 2019 | |
| Supernus Pharmaceuticals, INC. | $14.24 | 2025 | Qelbree |
| Gynesonics, INC. | $14.11 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Meditrina | $13.95 | 2024 | |
| Smith+Nephew, INC. | $12.78 | 2023 | Pico 7 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Mullins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.